Oramed Pharmaceuticals
ORMP
$2.20
Share price
-1.35%
Change (1 day)
-12.70%
Change (1 year)
Categories
Revenue for Oramed Pharmaceuticals (ORMP)
Revenue in 2025 (TTM): $2 Million USD
According to Oramed Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is $2 Million USD. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of $1.34 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Oramed Pharmaceuticals from 2009 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $2 M | |
| 2024 | N/A | -100% |
| 2023 | $1.34 M | -50.43% |
| 2022 | $2.7 M | 0% |
| 2021 | $2.7 M | -0.26% |
| 2020 | $2.71 M | 0.26% |
| 2019 | $2.7 M | 7.6% |
| 2018 | $2.51 M | 2.24% |
| 2017 | $2.45 M | 96.4% |
| 2016 | $1.25 M | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Ultragenyx Pharmaceutical RARE | $0.59 B | 29,434.45% | 🇺🇸 USA |
 Novo Nordisk NVO | $43.73 B | 2,186,418.37% | 🇩🇰 Denmark |
 Sanofi SNY | $47.39 B | 2,369,812.53% | 🇫🇷 France |
 Compugen CGEN | $27.58 M | 1,279.45% | 🇮🇱 Israel |
 Lexicon Pharmaceuticals
LXRX | $31.21 M | 1,460.65% | 🇺🇸 USA |